Filter Results :

Your search for therapies returned 95 reports

Sort by


Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis Review

04 Mar 2015  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company. It discovers and develops medicines for the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and other cognitive disorders; and inflammatory and fibrotic diseases. The company...

$ 300.00

Read More

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

04 Mar 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 300.00

Read More

Incretin-Based Drugs: Markets for Diabetes Therapies and Developing Treatments

24 Feb 2015  |  Published by:  BCC Research
The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a compound annual growth rate (CAGR) of 12.4% from 2014 to 2019. This report provides:-An overview of the glob...

$ 6,650.00

Read More

Vital Therapies, Inc. (VTL) - Medical Equipment - Deals and Alliances Profile

10 Feb 2015  |  Published by:  GlobalData
SummaryVital Therapies, Inc. (Vital Therapies) is a healthcare company. The company provides treatment of liver failure with the development of ELAD. Its ELAD product is a human-cell-based bioartificial liver. Vital Therapiesí ELAD is designed to stabilize liver function in patients with life-threat...

$ 250.00

Read More

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

10 Feb 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 250.00

Read More

Regenerative Medicine and Stem cell based Cell therapies-Drugs of the Future Offering Hope for Cure

21 Jan 2015  |  Published by:  MP Advisors
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. Improved health care, nutrition and preventive medicine in the last few decades have all helped in increasing the life expectancy WW. However, this has not t...

$ 3,000.00

Read More

Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets

21 Jan 2015  |  Published by:  MP Advisors
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space...

$ 2,000.00

Read More

Physician Views: Are dermatologists ready for a new class of psoriasis therapies?

21 Jan 2015  |  Published by:  FirstWord
Novartis has become the first player to bring to market an interleukin-17A inhibitor, most recently announcing on Monday that the European Commission approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis. Approval in the US market for the same indication is also expected in t...

$ 695.00

Read More

Advanced Catheter Therapies, Inc. - Medical Equipment - Deals and Alliances Profile

12 Jan 2015  |  Published by:  GlobalData
SummaryAdvanced Catheter Therapies, Inc. (ACT) is an early stage medical device research and development company. The company provides new catheter technologies for vascular disease including inflammation, thrombosis, occlusions and restenosis. ACT is developing a device for restenosis (re-blockage ...

$ 250.00

Read More

Biological Therapies for Cancer: Technologies and Global Markets

06 Jan 2015  |  Published by:  BCC Research
The global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. This report provides:-An overview of the global markets and technologies for b...

$ 6,650.00

Read More

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

18 Dec 2014  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 250.00

Read More

OncoVista Innovative Therapies, Inc. (OVIT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Nov 2014  |  Published by:  GlobalData
SummaryOncoVista Innovative Therapies, Inc. (OncoVista) is a biopharmaceutical company. It focuses on developing targeted anticancer therapies by using biomarkers that are associated with tumors. The company produces therapeutics that deliver drugs selectively based on the biochemical characteristic...

$ 250.00

Read More

Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Nov 2014  |  Published by:  GlobalData
SummaryImmunovative Therapies, Ltd. (ITL) is a biopharmaceutical company. The company develops immunotherapy drug products for treatment of cancer and infectious disease. It offers products that include allovax, allostim, cryostim, indications and animations. ITL develops products based on mirror ef...

$ 250.00

Read More

Intra-Cellular Therapies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Nov 2014  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The company develops novel drugs for the treatment of diseases and disorders of the central nervous system. ITIís products include ITI-007, ITI-002, and ITI-009. The companyís ITI-007 is a clinical stage drug candidate desig...

$ 250.00

Read More

Biotie Therapies AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

12 Nov 2014  |  Published by:  GlobalData
SummaryBiotie Therapies AG (Biotie) formerly Synosia Therapeutics AG is a pharmaceutical company. The company manufactures and distributes drugs for neurodegenerative and psychiatric disorders, inflammatory and fibrotic liver disease. Biotie also provides clinical development programs and research s...

$ 250.00

Read More
Total 95 records.